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Introduction
In developing countries, intestinal parasitic infection 
in immunodeficient patients including, organ transplant 
recipients, cancer and common variable immunodeficiency 
patients needs careful consideration. Opportunistic 
infections are the cause of diarrhea in patients with 
HIV/AIDS (Khanaliha et al., 2015) and patients under 
some kind of immunosuppression drugs (Rasti et al., 
2017).
Nowadays the increasing use of transplants (kidney, 
bone marrow, liver, heart, etc.) and the use of new 
immunosuppressive drugs in patients with cancer and 
primary autoimmune diseases are observed. (Ferreira and 
Borges, 2002).
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The most frequently reported malignancies were 
stomach cancer in males and breast cancer in females 
in Tehran, Iran during 1998 – 2001 (Mohagheghi et al., 
2009). Colorectal cancer (CRC) is one the most common 
cancers worldwide.  This cancer is the third most common 
cancer among Iranian men. According to the results of a 
study, the incidence of colorectal cancer has increased in 
Iran during 2003 and 2008 (Rafiemanesh et al., 2016).
It is demonstrated that oxidative stress plays a critical 
role in the molecular mechanisms of colorectal cancer 
(CRC) and is shown to be associated with Blastocystis sp, 
that is the most common intestinal protozoa (Kumarasamy 
et al., 2017). The pathogenicity of Blastocystis sp. is 
associated with some disease like acquired immune 
deficiency syndrome (AIDS) (Fisseha et al., 2017) and 
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colorectal cancer (CRC) (Chandramathi et al., 2014). 
Blastocystis sp in CRC patients during chemotherapy 
treatment displays opportunistic nature of Blastocystis  sp 
in these patients(Chandramathi et al., 2012). 
The second most prevalent primary immunodeficiency 
is common variable immunodeficiency (CVID) disease. 
CVID is a combination of humoral and cell-mediated 
deficiency. It is defined as hypogammaglobulinemia 
associated with IgG and IgA immunoglobulin deficit 
whereas the immunoglobulin M (IgM) concentration 
can be normal or low (Chapel and Cunningham-Rundles, 
2009). An increased risk of malignancy especially 
lymphoma and gastric cancer is associated with CVID and 
malignancy is diagnosed as one of the five clinical CVID 
phenotypes (Chapel et al., 2008; Mortaz et al., 2016).
Although intravenous immunoglobulin therapy was 
performed on CVID patients because of   the defects 
of T-cell-mediated,  the gastrointestinal disorders were 
observed (Kalha and Sellin, 2004).The intestinal  parasitic 
infection like Giardia lamblia, Cryptosporidium parvum 
are common in patients with primary immunodeficiencies 
(PIDs) patients group (Aguilar et al., 2014).
Parasitic infections rate in organ transplant recipients 
is unknown, however few patients are symptomatic (Thom 
and Forrest, 2006).Only 5% of known human pathogenic 
parasitic infections which have serious morbidity have 
been reported in transplant recipients (Barsoum, 2004). 
The transplant clinicians should be highly suspicious of 
parasitic infections as an important transmission threat 
(Barsoum, 2004). 
Cryptosporidium is a coccidian intestinal protozoan, 
which is often found in the human intestine that can cause 
severe diarrhea in the immunocompromised patient. It 
is an infamous infection in ileum transplants (Pozio et 
al., 2004), but has also been reported as a recrudescence 
disease in recipients of liver (Campos et al., 2000), kidney 
(Minz et al., 2004) , and bone marrow transplants (Müller 
et al., 2004).Cryptosporidium should be differentiated 
from other protozoa, Isospora belli and Cyclospora 
cayetanensis in immunocompromised patients (Verweij 
and Stensvold, 2014).
The genus Cryptosporidium consist of over 20 species 
which species like C. parvum from C. hominis are 
indistinguishable morphologically (Peralta et al., 2016). 
Cryptosporidium infection in both immunocompromised 
and immunocompetent individuals may be found by 
different species and genotypes (Cama et al., 2007). 
Microsporidia are intracellular spore-forming protozoa 
that are present in the environment and can infect the 
intestine of insects, birds, and mammals. The diagnosis 
was made by staining and molecular method (Agholi et al., 
2013a; Khanaliha et al., 2014). Enterocytozoon bieneusi in 
patients with HIV disease was reported in several studies 
(Agholi et al., 2013a). 
The aim of this study is to evaluate the prevalence of 
intestinal parasites in different groups of patients including 
organ transplants recipients, cancer group and primary 
immunodeficiency referred to Milad hospital and three 
general hospitals namely Ali-Asghar, Rasoul-e-Akram 
hospital, and Rajaie Heart Hospital associated with Iran 
University of Medical sciences, Tehran, Iran.
Materials and Methods 
This cross-sectional study was performed between 
July 2016 and November of 2017 including 80 patients 
with Primary Immunodeficiency, 85 cancer patients and 
25 organ transplant recipients who were referred to Milad 
hospital and three general hospitals namely Ali-Asghar, 
Rasoul-e-Akram hospitals and Rajaie Heart Hospital 
associated with Iran University of Medical Sciences, 
Tehran, Iran. 
Stool examination
Stool samples were collected from 190 patients 
referred to hospitals associated with Iran University of 
Medical Sciences and transferred to Research Center of 
Pediatric Infectious Diseases, Institute of Immunology and 
Infectious Diseases, Iran University of Medical Sciences. 
Furthermore, they were examined by direct examination 
with PBS and then formalin ether concentration was 
performed and finally examined under microscope with 
100x and 400x as final magnification. The modified acid 
fast staining method was applied for the detection of 
coccidia parasites infection. The smears were prepared 
and stained by the modified Ziehl–Neelsen stain. The 
aniline blue staining method was used to detect spores 
of microsporidia as described before (Ghaderipour et 
al., 2017).
DNA extraction
All of samples were positive for Cryptosporidium and 
microspora by Ziehl–Neelsen technique and aniline blue 
staining method respectively were used in PCR.  DNA 
extraction was performed by (Roche Diagnostics GmbH, 
Mannheim, Germany) according to the manufacturer’s 
instructions
Cryptosporidium
The nested PCR was performed and an 837 bp 
fragment amplified of the 18S rRNA gene. The primers 
were used for nested PCR primers described by Santin et, 
al (Santín et al., 2006).
5 ′ - T T C TA G A G C TA ATA C AT G C G - 3 ′  a n d 
5′-CCCATTTCCTTCGAAACAGGA-3′ for primary PCR 
and 5′-GGAAGGGTTGTATTT-ATTAGATAAAG-3′ and 
5′-AAGGAGTAAGGAACAACCTCCA-3′ for secondary 
PCR.
PCR was performed in a 25 µL mixture containing the 
template (3 µL of DNA), 2.5 U of Taq DNA  polymerase, 
2.5 µL of 10x PCR buffer, 20 pmol of each primer, 100 
µmol dNTPs, and 0.15 mmol MgCl2. After an initial start 
at 94 oC for 3 min, each of cycles consisted of 94 oC for 45 
s, 59 oC for 45 s and72 oC for 1 min for 35 cycles and ends 
with 72oC for 7 min. The second round was performed 
by the cycling program consisting of 40 cycles 94 oC for 
30 s, 58 oC for 90 s, 72 oC for 20 min, with an initial at start 
94 oC for 3 min and ended with 72 oC for 7 min. Finally, 
PCR products were electrophoresed on 1 % agarose gel. 
The positive control was used in each step of PCR and 
distilled water was used as a negative control.
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and colon cancer and 25 organ transplant including liver, 
kidney and heart were evaluated for parasitic infection 
Out of 80 CVID positive patients, 41 (51.2%) were 
male and 39 (48.8%) were female and among 85 cancer 
group patients, 48(56.5%) were male and 37 (43.5%) were 
female and of 25 organ transplant recipients 19 (76%) 
were males and 6 (24%) were females. The patient age 
was between 5-65 years old with the mean age 34 year.
In general, the prevalence of parasites were 26/80 
(32.5%) in primary immunodeficiency, 22/85 (25.9%) 
in cancer group, 7/25 (28%) in organ transplant. The 
rate of infection was higher in male (31.2%) than female 
Enterocytozoon bieneusi
The nested PCR was carried out using E. bieneusi 
specific primers that amplified the ITS region as well as a 
portion of the flanking large and small subunit ribosomal 
RNA genes (Santín et al., 2006)
T h e  o u t e r  p r i m e r s  w e r e  E B I T S 3 
(5′-GGTCATAGGGATGAAGAG-3′) and EBITS4 
(5’-TTCGAGTTCTTTCGCGCTC-3’). The inner primers 
were EBITS1 (5’-GCTCTGAATATCTATGGCT-3′) and 
EBITS2.4 (5′-ATCGCCGACGGATCCAAGTG-3′). 
Finally, these reactions produced a fragment of 389 bp
The reaction mixture (25 µL) contained 2.5 µL of 
10x PCR buffer 0.15 mmol MgCl2, 100 µmol dNTPs, 20 
pmol of each primer, 2.5 U of Taq. The PCR started with 
denaturation at 94 oC for 5 min, 35 cycles of amplification 
(denaturation at 94 oC for 30 s, annealing at 57oC for 30 
s, and elongation at 72oC for 40 s) and then was followed 
by a final extension at 72 oC for 10 min. The annealing 
temperature for the second round of PCR was 55 oC and 
other condition was identical with first round of PCR 
(Santín et al., 2006).
Ethical issues
The present study was approved by the Ethics 
Committee of Iran University of Medical Sciences in 
accordance with the Helsinki Declaration and Guidelines. 
It also should be mentioned that informed consent was 
obtained from all patients for the present study. 
Sequencing: The second round of PCR was done using 
inner primers and PCR products were purified by the High 
Pure PCR Product Purification Kit (Roche Diagnostic, 
Mannheim, Germany) and were used for direct sequencing 
using the dye termination method and an ABI 3730xl 
sequencer (Khanaliha et al., 2017).
The new sequences of Cryptosporidium and E. bieneusi 
were deposited in GenBank database and compared with 
deposited sequences by BLAST analysis.  
Statistical analysis: Analysis was done using SPSS 
version 18 (Chicago, IL, USA) and Chi-square test was 
used to analyze statistical relationship. A statistically 
significant P value of < 0.05 was accepted.
Results
Overall 190 patient consist of 109 (57.4%) males 
and 81 (42.6%) females including 80 CVID and Bruton 
agammaglobulinemia, 85 cancers group patients: 
lymphoma cancer, lymphosarcoma, hepatoblastoma, lung 
parasites Primary immunodeficiency No: 80 Transplant recipients No:25 Cancers Patients No:85
Male Female Male Female Male Female
Blastocystis hominis 6 (7.5%) 7 (8.75%) 0 0 12 (14.1%) 7 (8.2%)
Giardia lamblia 6 (7.5%) 4 (5%) 0 0 2 (2.3%) 0
*Cryptosporidium spp. 0 1 (1.25%) 5 (20%) 1 (4%) 0 0
Chilomastix mesnilii 0 1 (1.25%) 0 0 0 0
Dientamoeba fragilis 1 (1.25%) 0 0 0 1 (1.2%) 0
*Microspora 0 0 1 (4%) 0 0 0
Total 13 (16.25%) 13 (16.25%) 6 (24%) 1 (4%) 15 (17.6%) 7 (8.2%)
Table 1.Prevalence of Intestinal Parasitic Infection among Different Groups of Patients
Figure 1. Appearance of Cryptosporidium Oocyst 
in Stool Samples Collected from Organ Transplant 
Recipients by Modified Acid Fast Staining Method, 
1000x Magnification (Origin Picture).
Figure 2. Appearance of E. bieneusi Spores in Stool 
Samples Collected from Heart Transplant Recipient by 
Aniline Blue Staining Method, 1,000x Magnification 
(Origin Picture).
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(18.9%) cancer patients and also in male (31.5%) and 
female (16.6%) OTR patients, but differences were not 
statistically significant (P value = 0.1) (P value = 0.4). 
The rate of infection was (31.7%) in male and (33.3%) 
in female CVID patients and differences were not 
statistically significant (P value = 0.4).
The prevalence of intestinal parasitic infection in 
primary immunodeficiency patients was Blastocystis 
hominis 13 (16.2%), Giardia lamblia 10 (12.5%), 
Cryptosporidium 1 (1.2%), Chilomastix mesnilii 1 (1.2%), 
Dientamoeba fragilis 1 (1.2%).
Among 85 cancers patients including 39 colorectal 
cancer and 46 cancers outside gastrointestinal tract  (COGT) 
like lymphoma, lymphosarcoma, hepatoblastoma, lung 
cancer 19 (22.3%) Blastocystis hominis and two (2.3%) 
Giardia lamblia and one Dientamoeba fragilis 1(1.1%) 
were found. Blastocystis hominis were identified in 11/39 
(28.2%) among CRC group and 8/46 (17.4%) among 
COGT patients. Although Blastocystis hominis was more 
common among CRC group patients than COGT ones, the 
difference between groups wasn’t statistically significant 
(P value= 0.17). 
The results of this study show; 6 (24%) Cryptosporidium 
sp were found in 25 organ transplant recipients including 
(OTR) including liver, kidney and heart transplant. The 
oocyst of Cryptosporidium was found in three liver, 
two kidney and one heart transplant recipients and 
one additional Cryptosporidium sp was identified in 
primary immunodeficiency patients by acid fast staining 
method (Figure 1). One microspora 1 (4%) was found 
in a heart transplant recipient using aniline blue staining 
method (Figure 2). All of patients with cryptosporidiosis 
and microsporidia infection had diarrhea as a clinical 
manifestation. 
Microspora confirmed as E. bieneusi in a heart 
transplant recipients by PCR sequencing in this study. The 
results of prevalence of parasitic infection are summarized 
in Table 1.
There was no statistically significant difference 
between the prevalence of parasitic infection in cancer, 
CVID and OTR patients in this study (P value= 0.22; 
P value= 0.43), however, the difference between 
Cryptosporidium infection in OTR patients with CVID 
and OTR with cancer patients were statistically significant 
(P value= 0.0001)
PCR and Sequencing
The result of Cryptosporidium PCR is shown in 
Figure 3.The band of 837 bp fragment of the 18S rRNA 
gene related to Cryptosporidium was amplified from 
fecal specimens of patients by nested PCR protocol. 
All PCR positive samples were sequenced to identify 
the species. The obtained sequences were deposited and 
compared with other deposited sequences in the GenBank 
database by BLAST analysis. All of 7 patients infected 
with Cryptosporidium were also confirmed as C. parvum 
by PCR sequencing. The isolates had 100% similarity 
with the C. parvum genotype 1 (Gen Bank accession no. 
L16997).
The deposited sequences Gen Bank accession numbers 
for Cryptosporidium were: MH215510, MH215511, 
MH215512, MH215513, MH215514, MH215515, and 
MH215516 in this study.
Enterocytozoon bieneusi was identified in a heart 
transplant recipient by PCR sequencing. A band of 389 
bp was observed in agarose gel electrophoresis of PCR 
product (Figure. 4). E. bieneusi isolate had 99% identity 
with G2-J9, 536 and CHN1 and genotype J in this study. 
The deposited sequences GenBank accession no for E. 
bieneusi was MH243443.
Discussion
Paras i t ic  in fec t ions  a re  among the  most 
important pathogens that can cause infections in 
immunocompromised individuals (Ferreira and Borges, 
2002). Patients with impaired cellular immunity, like 
neoplasia, renal or heart transplant patients are at risk of 
protozoa infection (Ferreira and Borges, 2002).
In this study Blastocystis hominis with the prevalence 
of 19 (22.3%) was found as the most prevalent parasitic 
infection among cancers patients. Blastocystis hominis 
11/39 (28.2%) was detected more frequently in CRC 
group than COGT patients 8/46 (17.4%).
Figure 3. PCR Products of Cryptosporidium in Iranian 
Transplant Recipients. 1, DNA Ladder Marker; 2, 
Negative Control; 3, Negative Patient; 4, 5, 6, Positive 
Patients; 7, Positive Control.
Figure 4. PCR Products of E. bieneusi in Iranian 
Transplant Recipient; 1, DNA Ladder Marker (100 bp); 
2, Positive Control; 3, Positive E. bieneusi Patients (389 
bp); 4, Negative Control
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Prevalence of Blastocystis sp is relatively high in 
developing countries (Tan, 2008) and it was reported as 
the most common parasites in Iran (Mahni et al., 2016).
The result of a study demonstrated that Blastocystis 
sp. has a significant role in enhancing Azoxymethane 
(AOM) -induced carcinogenesis damage to the intestinal 
epithelium and oxidative damage were observed in rats 
infected with Blastocystis sp and the study proposed that 
Blastocystis sp. is a pathogen protozoa so it is necessary 
to screen cancer patients for this parasite (Kumarasamy 
et al., 2017). 
The prevalence of Blastocystis sp in CRC patients 
was 33.3% in comparison with 25% in cancers outside 
gastrointestinal tract (COGT) and 15% in non-cancer 
(NC) patients in a study and the result suggested a possible 
association between subtype-I of Blastocystis hominis and 
CRC, which could reveal  an important role of Blastocystis 
on CRC condition (Mohamed et al., 2017).
Microsporidiosis has been reported in HIV positive 
patients but more recently, has been diagnosed in 
non–HIV-infected individuals (Agholi et al., 2013a; 
Ghaderipour et al., 2017).
Several studies have reported microsporidial infections 
in organ transplant recipients, however these infections 
have not been proved to be transplant-transmitted 
(Lanternier et al., 2009; Galván et al., 2011). The 
microsporidiosis have been reported in solid transplant 
recipients (Carlson et al., 2004), microsporidia were found 
in kidney recipients (Mohindra et al., 2002; Galván et al., 
2011; Visvesvara et al., 2013), pancreas-kidney (Carlson 
et al., 2004) and heart transplants(Gumbo et al., 1999).
In the present study, E. bieneusi was found in a 
ten-year-old heart transplant patient who had chronic 
diarrhea and had received transplant for more than two 
years. Comparing the new sequence with the result of 
deposited ones, it was indicated that the E. bieneusi isolate 
had 99% identity with isolates G2-J9, 536 and CHN1 and 
genotype J in this study
Genotype CHN1 was previously detected in human 
and cattle as the most common genotype and genotype 
CHN2 was found only in human samples in a study (Zhang 
et al., 2011). 
In a study on among 44 liver transplant children in 
Shiraz 6.81% Enterocytozoon bieneusi (genotype D) and 
11.36% C. parvum and C. Meleagridis were identified 
(Agholi et al., 2013b).
Cryptosporidium infection is more common in 
overcrowded societies with low degrees of sanitation (Brink 
et al., 2002) There are few studies on cryptosporidiosis in 
Iran (Azami et al., 2007). The previous reports indicated 
the prevalence of this infection in diarrhea patients which 
was 4.7% (Sulaiman et al., 2002) and in HIV-patients 
which was reported 1.5% (Guyot et al., 2001; Zali et al., 
2004). 
Giardia lamblia and Cryptosporidium parvum 
are two parasites that may be found during Primary 
Immunodeficiency infection like agammaglobulinemia, 
CVID and Hyper-IgM syndrome with cellular defect, 
however, among the last cases, Cryptosporidium parvum 
is more common (Aguilar et al., 2014).
In the present study, Blastocystis hominis 13 (16.2%), 
and Giardia lamblia 10 (12.5%) were the most prevalent 
parasites especially in primary immunodeficiency patients 
and one case cryptosporidium parvum 1 (1.2%) was 
identified in a patient with CVID who suffered from 
chronic diarrhea.
Blastocystis hominis (4.2%) and Giardia lamblia 
(3.0%) were also reported as the most prevalent parasites 
in immunocompromised patients in the previous study 
(Rasti et al., 2017).
In a study which was performed in Turkey, the most 
common parasites diagnosed were Cryptosporidium spp, 
Giardia spp and Blastocystis spp, among  CVID patients 
with clinical manifestation especially diarrhea (Uysal et 
al., 2016) . 
The most common Cryptosporidium infection was 
found more in organ transplant patients than cancer or 
patients with primary Immunodeficiency in the present 
study. All organ transplant recipients had received 
transplant for more than 1 year. Overall, 7 cases of 
Cryptosporidium identified that six of them were found 
in organ transplant recipients including liver, kidney 
and heart transplant recipients and one additional 
Cryptosporidium was detected in a CVID patient by acid 
fast staining. The result of PCR and sequencing show 
that all of them had 100% similarity with the C. parvum 
genotype 1, human genotype (GenBank accession no. 
L16997) and 99% similarity with C. parvum strain Human 
genotype (HFL2) (GenBank accession no. AF093491). 
In a study, four Cryptosporidium genotypes in HIV 
patients were identified: C. parvum genotype 1 (human), 
C. parvum genotype 2 (bovine), a genotype related to C. 
felis, and one genotype was similar to a Cryptosporidium 
sp. The corresponding sequences of the C. parvum 
genotype 1 SSU-rRNA were identical (GenBank accession 
number L16997) (Pieniazek et al., 1999).
A study which was carried out on immunocompromised 
Egyptian patients Giardia lamblia with prevalence of 
(10%) showed the most common parasite identified among 
patients. Other parasites were Cryptospotidium parvum 
(7%) Cyclospora cayetanensis (3%) and Microsporidia 
species (2%) (Baiomy et al., 2010).
The presence of C parvum , C hominis , and 
C meleagridis was confirmed in three patients with 
primary immunodeficiency by molecular method 
(Wolska-Kusnierz et al., 2007).
In a study, the 13 Cryptosporidium isolates from 
immunocompromised patients from Isfahan were 
evaluated and eight of them were infected with the C. 
parvum genotypes (GenBank accession no. L 16997) 
(Azami et al., 2007). C. parvum sequences, in the present 
study, had also 100% similarity with C. parvum genotypes 
(GenBank accession no. L 16997)
C. parvum isolates were detected among human and 
cattle and the L1 subgenotype was the most prevalent 
and was diagnosed in eight human cases out of nine and 
in all cattle cases, in a study (Meamar et al., 2007).It has 
been reported C. parvum cattle genotype are predominant 
among C. parvum isolates from human in some previous 
study (Azami et al., 2007; Meamar et al., 2007). 
Cancer patients especially CRC group had the highest 
rate of infection with Blastocystis hominis in this study, 
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so screening of this protozoon for this group of patients 
with regard to the role of this parasite in oxidative damage 
to intestinal epithelium is recommended. Furthermore, 
Blastocystis hominis and Giardia lamblia were the 
most prevalent parasites in primary immunodeficiency 
and opportunistic infection like Cryptosporidium and 
E. bieneusi which were found more in OTR than primary 
immunodeficiency (CVID and Bruton), so these patients 
should be considered for opportunistic infection.
Patients with primary Immunodeficiency received 
azitromycine and were under prophylactic treatment  in this 
study, so this may be a reason for reducing opportunistic 
infection like microspora and cryptosporidium in this 
group.
In general patients with impaired T-cell function 
especially to a CD4 counts of less than 50/mm3, 
whether it is inherited or acquired immunocompromised 
disease or patients under treatment depending on 
degrees of immune-suppression, are at higher risk of 
Cryptosporidium and microspora infection (Hunter and 
Nichols, 2002).
Overall, immunodeficient patients with clinical 
manifestation and impaired cellular immunity and under 
treatment of immune suppression should be considered 
for opportunistic parasitic infection.
In conclusion, the high rate of infection with 
Blastocystis hominis was found in cancer patients 
especially CRC patients, so careful consideration should 
be given by physicians. Cryptosporidium parvum was 
found to be the major cause of parasitic intestinal infection 
in patients with organ transplant compared to other 
CVID patients, so organ transplant recipients undergoing 
immunosuppressive treatment should be considered a risk 
group for acquiring microsporidia and Cryptosporidium 
infection. 
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